BD Announces 510(k) Clearance of Pristine™ Long-Term Hemodialysis Catheter
Share this article Share this article FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Pristine™ Long-Term Hemodialysis Catheter, a new hemodialysis catheter with a unique side-hole free symmetric Y-Tip™ distal lumen design. The Pristine™ Catheter will be available in the U.S. in May 2021...
United States Paul Tyahla Padraic Obrien Kristenm Stewart Pristine Access Technologies Ltd Padraico Brien
Source: prnewswire.com